NYSE:CHE - Chemed Stock Price, Forecast & News

Chemed trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

Chemed declared a quarterly dividend on Friday, November 1st. Investors of record on Monday, November 11th will be paid a dividend of $0.32 per share on Monday, December 2nd. This represents a $1.28 annualized dividend and a dividend yield of 0.26%. The ex-dividend date of this dividend is Thursday, November 7th. View Chemed's Dividend History.

Chemed declared that its Board of Directors has authorized a share buyback plan on Wednesday, March 7th 2018, which allows the company to buyback $150,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to purchase shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its stock is undervalued.

Chemed Co. (NYSE:CHE) issued its earnings results on Tuesday, February, 18th. The company reported $4.22 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.09 by $0.13. The company earned $522.30 million during the quarter, compared to analyst estimates of $524.20 million. Chemed had a net margin of 11.35% and a return on equity of 36.80%. Chemed's revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $3.35 EPS. View Chemed's Earnings History.

Chemed is scheduled to release their next quarterly earnings announcement on Monday, May 4th 2020. View Earnings Estimates for Chemed.

Chemed issued an update on its FY20 earnings guidance on Tuesday, February, 18th. The company provided earnings per share (EPS) guidance of $16.20-16.50 for the period, compared to the Thomson Reuters consensus EPS estimate of $15.63.

4 equities research analysts have issued twelve-month target prices for Chemed's shares. Their forecasts range from $405.00 to $535.00. On average, they expect Chemed's share price to reach $482.50 in the next twelve months. This suggests that the stock has a possible downside of 1.0%. View Analyst Price Targets for Chemed.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Chemed.

News articles about CHE stock have trended somewhat negative recently, InfoTrie Sentiment reports. The research group ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Chemed earned a daily sentiment score of -1.9 on InfoTrie's scale. They also gave headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the next few days. View News Stories for Chemed.

Some companies that are related to Chemed include Laboratory Corp. of America (LH), Quest Diagnostics (DGX), BioScrip (BIOS), Davita (DVA), Amedisys (AMED), LHC Group (LHCG), AMN Healthcare Services (AMN), MEDNAX (MD), R1 RCM (RCM), CorVel (CRVL), Tivity Health (TVTY), The Providence Service (PRSC), Cross Country Healthcare (CCRN) and Interpace Diagnostics Group (IDXG).

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include Home Depot (HD), Altria Group (MO), AT&T (T), AbbVie (ABBV), CVS Health (CVS), Chevron (CVX), Walt Disney (DIS), Enterprise Products Partners (EPD), Occidental Petroleum (OXY) and Boeing (BA).

Chemed's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Acadian Asset Management LLC (3.26%), FMR LLC (2.83%), State Street Corp (2.49%), Riverbridge Partners LLC (2.29%), Investec Asset Management LTD (1.70%) and Geode Capital Management LLC (1.28%). Company insiders that own Chemed stock include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Institutional Ownership Trends for Chemed.

CHE stock was sold by a variety of institutional investors in the last quarter, including Boston Partners, Russell Investments Group Ltd., Barclays PLC, State Street Corp, Goldman Sachs Group Inc., Prudential Financial Inc., State of Tennessee Treasury Department and Smith Asset Management Group LP. Company insiders that have sold Chemed company stock in the last year include Andrea R Lindell, David Patrick Williams, Donald E Saunders, Frank E Wood, George J Walsh III, Kevin J Mcnamara, Michael D Witzeman, Naomi C Dallob, Spencer S Lee, Thomas P Rice and Walter L Krebs. View Insider Buying and Selling for Chemed.

CHE stock was acquired by a variety of institutional investors in the last quarter, including FMR LLC, BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp, Teacher Retirement System of Texas, Loomis Sayles & Co. L P, Marshall Wace North America L.P., Investec Asset Management LTD, Thrivent Financial for Lutherans and Bank of America Corp DE. Company insiders that have bought Chemed stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed.

Shares of CHE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CHE stock can currently be purchased for approximately $487.26.

Chemed has a market capitalization of $7.80 billion and generates $1.94 billion in revenue each year. The company earns $205.54 million in net income (profit) each year or $13.95 on an earnings per share basis. Chemed employs 15,707 workers across the globe.View Additional Information About Chemed.

The official website for Chemed is http://www.chemed.com/.

Chemed's mailing address is 255 EAST FIFTH STREET SUITE 2600, CINCINNATI OH, 45202. The company can be reached via phone at 513-762-6690.